APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026

19 December 2025207 pages

Choose your research edition.

Industry ResearchTetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market include Whistler, The Lab, Select Oil, Pharmahemp, NuLeaf Naturals, Medical Marijuana, Kazmira, K.I.N.D. Concentrates and HempLife Today, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tetrahydrocannabinol (THC) and Cannabidiol (CBD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Company

Whistler

The Lab

Select Oil

Pharmahemp

NuLeaf Naturals

Medical Marijuana

Kazmira

K.I.N.D. Concentrates

HempLife Today

Green Road

Freedom Leaf

Folium Biosciences

ENDOCA

Emblem Cannabis Oils

CW Hemp/CW Botanicals

CBD American Shaman

Canopy Growth Corporation

Cannavest

Aphria

Absolute Terps

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tetrahydrocannabinol (THC) and Cannabidiol (CBD) significant trends, drivers, influence factors in global and regions.

6. To analyze Tetrahydrocannabinol (THC) and Cannabidiol (CBD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) industry.

Chapter 3: Detailed analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends Table 2. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers Table 3. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges Table 4. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints Table 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Company (2021-2026) Table 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Company (2021-2026) Table 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Company Manufacturing Base & Headquarters Table 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company, Product Type & Application Table 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tetrahydrocannabinol (THC) Table 18. Significant Companies of Cannabidiol (CBD) Table 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Type (2021-2026) Table 23. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Type (2027-2032) Table 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type (2021-2026) Table 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceuticals Industry Table 30. Significant Companies of Food Industry Table 31. Significant Companies of Cosmetics Industry Table 32. Significant Companies of Other Table 33. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Application (2021-2026) Table 37. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Application (2027-2032) Table 38. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application (2021-2026) Table 42. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application (2027-2032) Table 43. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026) & (Tons) Table 45. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2021-2026) Table 46. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032) & (Tons) Table 47. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2027-2032) Table 48. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Region (2021-2026) Table 51. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Region (2027-2032) Table 53. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 58. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 59. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 60. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2027-2032) Table 61. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Market Share by Country (2021-2026) Table 63. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Market Share by Country (2027-2032) Table 65. Whistler Company Information Table 66. Whistler Business Overview Table 67. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 69. Whistler Recent Development Table 70. The Lab Company Information Table 71. The Lab Business Overview Table 72. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 74. The Lab Recent Development Table 75. Select Oil Company Information Table 76. Select Oil Business Overview Table 77. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 79. Select Oil Recent Development Table 80. Pharmahemp Company Information Table 81. Pharmahemp Business Overview Table 82. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 84. Pharmahemp Recent Development Table 85. NuLeaf Naturals Company Information Table 86. NuLeaf Naturals Business Overview Table 87. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 89. NuLeaf Naturals Recent Development Table 90. Medical Marijuana Company Information Table 91. Medical Marijuana Business Overview Table 92. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 94. Medical Marijuana Recent Development Table 95. Kazmira Company Information Table 96. Kazmira Business Overview Table 97. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 99. Kazmira Recent Development Table 100. K.I.N.D. Concentrates Company Information Table 101. K.I.N.D. Concentrates Business Overview Table 102. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 104. K.I.N.D. Concentrates Recent Development Table 105. HempLife Today Company Information Table 106. HempLife Today Business Overview Table 107. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 109. HempLife Today Recent Development Table 110. Green Road Company Information Table 111. Green Road Business Overview Table 112. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 114. Green Road Recent Development Table 115. Freedom Leaf Company Information Table 116. Freedom Leaf Business Overview Table 117. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 119. Freedom Leaf Recent Development Table 120. Folium Biosciences Company Information Table 121. Folium Biosciences Business Overview Table 122. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 124. Folium Biosciences Recent Development Table 125. ENDOCA Company Information Table 126. ENDOCA Business Overview Table 127. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 129. ENDOCA Recent Development Table 130. Emblem Cannabis Oils Company Information Table 131. Emblem Cannabis Oils Business Overview Table 132. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 134. Emblem Cannabis Oils Recent Development Table 135. CW Hemp/CW Botanicals Company Information Table 136. CW Hemp/CW Botanicals Business Overview Table 137. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 139. CW Hemp/CW Botanicals Recent Development Table 140. CBD American Shaman Company Information Table 141. CBD American Shaman Business Overview Table 142. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 144. CBD American Shaman Recent Development Table 145. Canopy Growth Corporation Company Information Table 146. Canopy Growth Corporation Business Overview Table 147. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 148. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 149. Canopy Growth Corporation Recent Development Table 150. Cannavest Company Information Table 151. Cannavest Business Overview Table 152. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 153. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 154. Cannavest Recent Development Table 155. Aphria Company Information Table 156. Aphria Business Overview Table 157. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 158. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 159. Aphria Recent Development Table 160. Absolute Terps Company Information Table 161. Absolute Terps Business Overview Table 162. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 163. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 164. Absolute Terps Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List Table 168. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Image Figure 2. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2032) & (Tons) Figure 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tetrahydrocannabinol (THC) Image Figure 10. Cannabidiol (CBD) Image Figure 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Type (2021-2032) Figure 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type (2021-2032) Figure 17. Pharmaceuticals Industry Image Figure 18. Food Industry Image Figure 19. Cosmetics Industry Image Figure 20. Other Image Figure 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Application (2021-2032) Figure 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application (2021-2032) Figure 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)
Applications
  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other
Companies covered
  • Whistler
  • The Lab
  • Select Oil
  • Pharmahemp
  • NuLeaf Naturals
  • Medical Marijuana
  • Kazmira
  • K.I.N.D. Concentrates
  • HempLife Today
  • Green Road
  • Freedom Leaf
  • Folium Biosciences
  • ENDOCA
  • Emblem Cannabis Oils
  • CW Hemp/CW Botanicals
  • CBD American Shaman
  • Canopy Growth Corporation
  • Cannavest
  • Aphria
  • Absolute Terps

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032)
  4. 1.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume (2021-2032)
  5. 1.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Dynamics
  1. 2.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends
  2. 2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers
  3. 2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges
  4. 2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints
3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Company
  1. 3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Revenue Ranking in 2025
  2. 3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Company (2021-2026)
  3. 3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Company (2021-2026)
  4. 3.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price by Company (2021-2026)
  5. 3.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Ranking (2024-2026)
  6. 3.6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Manufacturing Base and Headquarters
  7. 3.7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Product Type and Application
  8. 3.8 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Type
  1. 4.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Type Introduction
  2. 4.1.1 Tetrahydrocannabinol (THC)
  3. 4.1.2 Cannabidiol (CBD)
  4. 4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type
  5. 4.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type
  9. 4.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type (2021-2032)
5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Application
  1. 5.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Application Introduction
  2. 5.1.1 Pharmaceuticals Industry
  3. 5.1.2 Food Industry
  4. 5.1.3 Cosmetics Industry
  5. 5.1.4 Other
  6. 5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application
  7. 5.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application
  11. 5.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application (2021-2032)
6 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Regional Sales and Value Analysis
  1. 6.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2032)
  3. 6.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021-2026
  4. 6.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032)
  5. 6.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Region (2027-2032)
  9. 6.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032)
  12. 6.6.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032)
  15. 6.7.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032)
  21. 6.9.2 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
7 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Country-level Sales and Value Analysis
  1. 7.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  4. 7.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026)
  5. 7.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032)
  6. 7.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Whistler
  2. 8.1.1 Whistler Company Information
  3. 8.1.2 Whistler Business Overview
  4. 8.1.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  6. 8.1.5 Whistler Recent Developments
  7. 8.2 The Lab
  8. 8.2.1 The Lab Company Information
  9. 8.2.2 The Lab Business Overview
  10. 8.2.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  12. 8.2.5 The Lab Recent Developments
  13. 8.3 Select Oil
  14. 8.3.1 Select Oil Company Information
  15. 8.3.2 Select Oil Business Overview
  16. 8.3.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  18. 8.3.5 Select Oil Recent Developments
  19. 8.4 Pharmahemp
  20. 8.4.1 Pharmahemp Company Information
  21. 8.4.2 Pharmahemp Business Overview
  22. 8.4.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  24. 8.4.5 Pharmahemp Recent Developments
  25. 8.5 NuLeaf Naturals
  26. 8.5.1 NuLeaf Naturals Company Information
  27. 8.5.2 NuLeaf Naturals Business Overview
  28. 8.5.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  30. 8.5.5 NuLeaf Naturals Recent Developments
  31. 8.6 Medical Marijuana
  32. 8.6.1 Medical Marijuana Company Information
  33. 8.6.2 Medical Marijuana Business Overview
  34. 8.6.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  36. 8.6.5 Medical Marijuana Recent Developments
  37. 8.7 Kazmira
  38. 8.7.1 Kazmira Company Information
  39. 8.7.2 Kazmira Business Overview
  40. 8.7.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  42. 8.7.5 Kazmira Recent Developments
  43. 8.8 K.I.N.D. Concentrates
  44. 8.8.1 K.I.N.D. Concentrates Company Information
  45. 8.8.2 K.I.N.D. Concentrates Business Overview
  46. 8.8.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  48. 8.8.5 K.I.N.D. Concentrates Recent Developments
  49. 8.9 HempLife Today
  50. 8.9.1 HempLife Today Company Information
  51. 8.9.2 HempLife Today Business Overview
  52. 8.9.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  54. 8.9.5 HempLife Today Recent Developments
  55. 8.10 Green Road
  56. 8.10.1 Green Road Company Information
  57. 8.10.2 Green Road Business Overview
  58. 8.10.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  60. 8.10.5 Green Road Recent Developments
  61. 8.11 Freedom Leaf
  62. 8.11.1 Freedom Leaf Company Information
  63. 8.11.2 Freedom Leaf Business Overview
  64. 8.11.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  66. 8.11.5 Freedom Leaf Recent Developments
  67. 8.12 Folium Biosciences
  68. 8.12.1 Folium Biosciences Company Information
  69. 8.12.2 Folium Biosciences Business Overview
  70. 8.12.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  72. 8.12.5 Folium Biosciences Recent Developments
  73. 8.13 ENDOCA
  74. 8.13.1 ENDOCA Company Information
  75. 8.13.2 ENDOCA Business Overview
  76. 8.13.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  78. 8.13.5 ENDOCA Recent Developments
  79. 8.14 Emblem Cannabis Oils
  80. 8.14.1 Emblem Cannabis Oils Company Information
  81. 8.14.2 Emblem Cannabis Oils Business Overview
  82. 8.14.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  84. 8.14.5 Emblem Cannabis Oils Recent Developments
  85. 8.15 CW Hemp/CW Botanicals
  86. 8.15.1 CW Hemp/CW Botanicals Company Information
  87. 8.15.2 CW Hemp/CW Botanicals Business Overview
  88. 8.15.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  90. 8.15.5 CW Hemp/CW Botanicals Recent Developments
  91. 8.16 CBD American Shaman
  92. 8.16.1 CBD American Shaman Company Information
  93. 8.16.2 CBD American Shaman Business Overview
  94. 8.16.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  96. 8.16.5 CBD American Shaman Recent Developments
  97. 8.17 Canopy Growth Corporation
  98. 8.17.1 Canopy Growth Corporation Company Information
  99. 8.17.2 Canopy Growth Corporation Business Overview
  100. 8.17.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  102. 8.17.5 Canopy Growth Corporation Recent Developments
  103. 8.18 Cannavest
  104. 8.18.1 Cannavest Company Information
  105. 8.18.2 Cannavest Business Overview
  106. 8.18.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  108. 8.18.5 Cannavest Recent Developments
  109. 8.19 Aphria
  110. 8.19.1 Aphria Company Information
  111. 8.19.2 Aphria Business Overview
  112. 8.19.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  114. 8.19.5 Aphria Recent Developments
  115. 8.20 Absolute Terps
  116. 8.20.1 Absolute Terps Company Information
  117. 8.20.2 Absolute Terps Business Overview
  118. 8.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  120. 8.20.5 Absolute Terps Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Analysis
  2. 9.1.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Mode & Process
  6. 9.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors
  9. 9.2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst